Loading clinical trials...
Loading clinical trials...
Glioblastoma (GBM) is a highly malignant, incurable primary brain tumor. Due to the nature of this disease and the extent of the treatment (surgery followed by chemoradiation according to the Stupp trial) patients undergo considerable psychological distress. It is known that stress hormones are involved in a wide range of processes involved in cell survival, cell cycle and immune function, and can cause therapy resistance. In this study the effect of stress on outcome after chemoradiation in patients with GBM will be investigated.
Psychological stress will be measured using multiple approaches; Physiological measures, stress biomarker and questionnaires. Using this approach, a broad insight in the relationship between stress and outcome after chemoradiation will be obtained and the potential influence of physical activity and sleep evaluated. In addition, the results of this study will help to identify patients which experience high stress levels during chemoradiation to pilot (in the future) interventions to reduce stress before and during treatment.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Maastricht Radiation Oncology (Maastro)
Maastricht, Limburg, Netherlands
Verbeeten Insitute Tilburg
Tilburg, Netherlands
Start Date
June 1, 2022
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
March 4, 2026
42
ACTUAL participants
Smartwatch
DEVICE
Serum Cortisol
DIAGNOSTIC_TEST
Questionnaires
OTHER
Lead Sponsor
Maastricht Radiation Oncology
Collaborators
NCT07100730
NCT07420543
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions